293 results
An NSTEMI case due to a severe LM calcific sub-occlusive stenosis
22 Oct 2019
View this case of an 85-year-old woman, hypertensive under medical therapy with no previous medical or surgical history, who called the emergency services about chest pain and shortness of breath...
Author
Ticagrelor with or without aspirin in high-risk patients after PCI
07 Oct 2019
The TWILIGHT trial was designed to test the hypothesis that in patients undergoing PCI who are at high risk for ischemic or hemorrhagic complications and who have completed a 3-month course of DAPT with ticagrelor plus aspirin, continued treatment with ticagrelor monotherapy would be superior to ticagrelor...
Reviewer
ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome
03 Sep 2019
At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.
Author
Rapid NSTEMI Pathways in 2019: why every PCI centre needs one and how to set it up
Patrick Calvert (UK) explains to Dejan Milasinovic (Serbia) how his centre has set up a protocol to treat high-risk NSTEMI patients with the aim of achieving the guideline recommended time of 24 hours from presentation to Cathlab. They discuss the design of the system and what...
Mechanical circulatory support devices to protect patients during high-risk PCI
Performing high-risk percutaneous coronary intervention (PCI) in complex patients requires the interventional cardiologist to use mechanical circulatory support devices to achieve safer outcomes. Which patients are most at risk of complex PCI? What are the best mechanical circulatory support devices currently available and which has the strongest...
Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention
09 Jul 2019
Results of the SMART-CHOICE randomized clinical trial
Reviewer
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI
09 Jul 2019
Results of the STOPDAPT-2 randomized clinical trial
Reviewer
How should I treat a myocardial infarction with nonobstructive coronary arteries (MINOCA) in a young patient?
01 Jul 2019
A 20-year-old male with no history of previous illness presented to the emergency department because of chest pain that had started around three hours after physical exercise (soccer match)...
Extended DAPT: who & how can PEGASUS be applied in clinical practice?
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to learn more about PEGASUS, a trial designed to evaluate the potential benefit of DAPT beyond 1 year after a myocardial infarction, with or without stent implantation: to whom & how can extended DAPT be applied in clinical practice? Discover it now!
All you need to know about physiology
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to gain an update on physiology assessment options, learn more about how to correctly perform, interpret and implement physiology based assessments, and discover all about the future perspectives in this field.
What every interventional cardiologist should know about new cardiovascular drugs
Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...
Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease
03 Jun 2019
Reviewer
Reviewer
Trials and registries - Managing bleeding risk in search of optimal drug-device synergy
23 May 2019 – From EuroPCR 2019
Consult this session to discover the results of the latest trials and registries for the management of bleeding risk in search of optimal drug-device synergy: ROBOT-ACS, GLOBAL LEADERS, SAFE-A, and more!
Different approaches to challenging NSTEMI cases
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about tactical and strategic approaches to the invasive treatment on NSTEMI and to discover challenging clinical cases on NSTEMI.
Optimising anticoagulation management in atrial fibrillation: focus on patients with concomitant ACS and/or undergoing PCI
22 May 2019 – From EuroPCR 2019
Consult this session to learn about the current evidence in managing atrial fibrillation patients with concomitant acute coronary syndrome (ACS) and/or undergoing PCI, and to review the role of non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin for atrial fibrillation (AF).
Intracoronary imaging during PCI for ACS: cases where OCT did help... a lot!
22 May 2019 – From EuroPCR 2019
Consult this session to discover compelling cases of PCI for ACS where OCT helped a lot, such as cocaine and ergotamine abuse-related STEMI, double lumen coronary artery with flap-like structure, and more!
Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?
22 May 2019 – From EuroPCR 2019
Consult this session to learn through studies and clinical cases more about contemporary pharmacological strategies with intravenous antiplatelet therapy in PCI for STEMI, NSTEMI and complex stable coronary artery disease patients.
Novelties in treatment of complex ACS and STEMI patients
21 May 2019 – From EuroPCR 2019
Consult this session to discover various novelties for the treatment of complex acute coronary syndrome and STEMI patients, thanks to a selection of compelling clinical cases and studies.
The spectrum of ACS: novel findings
21 May 2019 – From EuroPCR 2019
Consult this session to discover the results of the latest studies regarding acute coronary syndrome (ACS) and how they may impact your clinical practice: DISCO, SMART-DATE, XIENCE, and more!
Pharmacotherapy before/during/after PCI
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about pharmacotherapy before / during / after PCI, and discover the results of various studies and trials: GLOBAL LEADERS, DUAL PCI, MATRIX, and more!
